Zimmer Biomet Holdings (ZBH) Depreciation & Amortization (CF) (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Depreciation & Amortization (CF) of $270.0 million for Q1 2026, up 6.13% year-over-year from $254.4 million in Q1 2025, and down 4.93% quarter-over-quarter from $284.0 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $270.0 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 6.13% year-over-year to $270.0 million; the TTM figure through Mar 2026 stood at $1.1 billion (up 9.61% YoY), while the FY2025 annual figure was $1.1 billion, up 9.79% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $270.0 million, down from $284.0 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $284.0 million in Q4 2025, with the low at $228.5 million in Q4 2022.
- The 5-year median for Depreciation & Amortization (CF) is $241.2 million (2023), against an average of $249.3 million.
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) fell 2.02% in 2022, then gained 13.03% in 2025.
- Zimmer Biomet Holdings' Depreciation & Amortization (CF) stood at $228.5 million in 2022, then climbed by 5.56% to $241.2 million in 2023, then advanced by 9.29% to $263.6 million in 2024, then increased by 7.74% to $284.0 million in 2025, then retreated by 4.93% to $270.0 million in 2026.
- Business Quant data shows ZBH's Depreciation & Amortization (CF) at $270.0 million in Q1 2026, $284.0 million in Q4 2025, and $283.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 270.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 270.80 Mn |
| Jun 30, 2026 | 270.80 Mn |
| Mar 31, 2026 | 270.00 Mn |
| Mar 31, 2026 | 270.00 Mn |
| Dec 31, 2025 | 284.00 Mn |
| Dec 31, 2025 | 284.00 Mn |
| Sep 30, 2025 | 283.60 Mn |
| Sep 30, 2025 | 283.60 Mn |
| Jun 30, 2025 | 271.80 Mn |
| Jun 30, 2025 | 271.80 Mn |
| Mar 31, 2025 | 254.40 Mn |
| Mar 31, 2025 | 254.40 Mn |
| Dec 31, 2024 | 263.60 Mn |
| Dec 31, 2024 | 263.60 Mn |
| Sep 30, 2024 | 250.90 Mn |
| Sep 30, 2024 | 250.90 Mn |
| Jun 30, 2024 | 243.20 Mn |
| Jun 30, 2024 | 243.20 Mn |
| Mar 31, 2024 | 238.60 Mn |
| Mar 31, 2024 | 238.60 Mn |